−160KRW
−8.43 BKRW
953.95 BKRW
38.65 M
About CHA BIOTECH
Sector
Industry
CEO
Sang-Hoon Oh
Website
Headquarters
Seoul
Employees (FY)
317
Founded
2002
ISIN
KR7085660009
FIGI
BBG000BRHBL1
Cha Biotech Co., Ltd. engages in the research of cell therapy and storage of cord blood. It operates through the following business: Cell Therapy Development, Bio, Chaum, and Bio Insurance. The Cell Therapy Development business develops and commercializes cell therapy. The Bio business offers cord blood bank. The Chaum business provides customized medical services for anti-aging. The Bio Insurance business offers storage services of premium and customized blood. The company was founded on November 6, 2002 and is headquartered in Seoul, South Korea.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of 085660 is 17190 KRW — it has increased by 0.06% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on KRX exchange CHA BIOTECH stocks are traded under the ticker 085660.
CHA BIOTECH is going to release the next earnings report on May 10, 2024. Keep track of upcoming events with our Earnings Calendar.
085660 stock is 2.05% volatile and has beta coefficient of 1.36. Check out the list of the most volatile stocks — is CHA BIOTECH there?
Yes, you can track CHA BIOTECH financials in yearly and quarterly reports right on TradingView.
085660 stock has risen by 4.06% compared to the previous week, the month change is a 9.48% fall, over the last year CHA BIOTECH has showed a 33.26% increase.
085660 net income for the last quarter is −16.73 B KRW, while the quarter before that showed 5.32 B KRW of net income which accounts for −414.35% change. Track more CHA BIOTECH financial stats to get the full picture.
Today CHA BIOTECH has the market capitalization of 967.48 B, it has increased by 3.27% over the last week.
No, 085660 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, 085660 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade CHA BIOTECH stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 25, 2024, the company has 317.00 employees. See our rating of the largest employees — is CHA BIOTECH on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So CHA BIOTECH technincal analysis shows the sell today, and its 1 week rating is neutral. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating CHA BIOTECH stock shows the buy signal. See more of CHA BIOTECH technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. CHA BIOTECH EBITDA is 24.59 B KRW, and current EBITDA margin is 2.98%. See more stats in CHA BIOTECH financial statements.